Search results
This clinical practice guideline from the American Society for Gastrointestinal Endoscopy provides an evidence-based approach for strategies to prevent post-ERCP pancreatitis. This document was developed using the Grading of Recom-mendations Assessment, Development and Evaluation framework.
9 wrz 2022 · Recommendation 2: For high-risk patients undergoing ERCP, the ASGE recommends that periprocedural rectal NSAIDs be given to prevent post-ERCP pancreatitis (strong recommendation/moderate quality of evidence).
1) Post-ERCP pancreatitis 2) Severe post-ERCP pancreatitis 3) Adverse events Critical Important 4. High risk for PEP Pancreatic stents No pancreatic stents 1) Post-ERCP pancreatitis 2) Severe post-ERCP pancreatitis 3) Adverse events Critical Important 5. Unselected patients undergoing ERCP Aggressive peri- and postprocedural hydration Standard ...
Post-ERCP pancreatitis was found to be the most frequent complication following ERCP, with an inci- dence of 3.47% (95% confidence interval [95%CI] 3.19%–3.75%).
16 mar 2021 · Pancreatitis is the most frequent complication resulting from endoscopic retrograde cholangiopancreatography (ERCP), affecting 4–10% of patients undergoing this procedure worldwide. 1 Although mortality due to post-ERCP pancreatitis is low (<1%), it can be morbid, with substantial annual health-care costs. 2 Multi-society guidance derived from m...
8 sie 2022 · Abstract. Post-endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis (PEP) is a dreaded complication. But the frequency of this complication varies widely (1%–40%) among the literature and across geographical regions.
American Society for Gastrointestinal Endoscopy guideline on post-ERCP pancreatitis prevention strategies: summary and recommendations. Gastrointest Endosc. 2023 Feb;97 (2):153-162. doi: 10.1016/j.gie.2022.10.005. Epub 2022 Dec 12.
